chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; low-grade fever; This is a spontaneous report from a contactable consumer (patient). A 62-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot number and expiration date was unknown), via an unspecified route of administration, administered in left arm on 05Mar2021 15:30 as a single dose for covid-19 immunization. Medical history included prostate cancer (underwent radiation treatment). Allergies to medications, food, or other products included penicillin. Concomitant medications included gabapentin, diazepam, naproxen, diclofenac and cyclobarbital, all taken for an unspecified indication from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. On 06Mar2021 10:00, 18hr 30 min, after vaccination, the patient experienced headache & low-grade fever day. The patient took 2 extra strength Acetaminophen as a treatment & headache began to feel lighter. The patient enquired did the treatment adversely affect the effectiveness of the vaccine by taking them. The outcome of the events was resolving.
This child received DTaP and IPV on the left upper arm and MMR and Hep A on the right upper arm. Her left upper arm is red, warm to touch and swollen since 03/01/01, vaccines given on 02/28/01. No fever. Full range of motion of arms both right and left. Patient sent to ER today 03/02/01.
Arm is swollen and painful. Patient mentions that she cannot move it and that it feels hard. Patient also experiencing chills.
5 minutes after administration the patient reported tingling and warming sensation of the tongue and lips. She was given 25 mg of oral diphenhydramine. After 10 minutes she reported that the symptoms were getting worse, upon visual inspection, it did not appear that her tongue, lips, mouth or throat were swelling. The patient refused an epi-pen and to call 911 as she felt there was no problem with breathing. She was given 50 mg of diphenhydramine intramuscular injection after refusing an epi-pen. After 10 minutes she said the tingling and warming sensation began to subside. She sat under observation for a total of an hour and 40 minutes after receiving the vaccine before leaving the site. Patient was highly encouraged to not be alone the rest of the day and to report to the ER if any further signs or symptoms developed.
On February 28th, she got a rash all over her legs and her feet were very swollen. She went to the emergency room on February 29th and they told her she possibly has vasculitis and it caused a full rash on both legs. she is doing further testing.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 51-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was reported that no treatment was given on the patients. No concomitant medications were reported.
Onset pulsating pain in shoulder radiating to back 6 hrs post vaccine.  No redness or swelling.  Unable to sleep 2 hour pain.  Much better post 24 hours pain unremarkable.
Body aches, malaise, mild fever, vertigo, light headedness, abdominal pain, 6/10 pain at vaccination site, tachycardia, chills, nausea.  All symptoms still ongoing at time of report.
Presented w/ 3 day history of worsening shortness of breath that has been progressive in nature; husband recently tested positive for COVID-19. Patient denies cough. She is markedly dyspnea with any type of mild exertion. Pt COVID-19+ w/pna; tx w/remdesivir, steroids, zinc, O2. Dc'd home on O2.
Pt had first time onset tonic clonic seizure. Transported to ER to R/O CVA vs. new onset seizure. Pt. hypoxic, altered mental status requiring admission.
Swelling, redness, itching of area surrounding injection site, approx. 2"x 4".
Moderna COCID-19 Vaccine Dose 1 was administered evening of 1/11/21. Initially had minor swelling and redness at injection site with minor pain, similar to flu shot, which lasted approximately 48 hours. 48 hours after injection, had chills with no fever for approximately one hour. After that symptom, no concerning symptoms occurred until evening of 1/18/21. Redness, swelling, and itchiness approximately the size of a quarter began. Morning of 1/19/21, size of redness and swelling had increased to size of baseball with itching. Evening of 1/19/21, size had increased to softball with continued itching. Area was raised, hard, and warm. Morning of 1/20/21, area had grown further and was starting to wrap around sides of arm and have ?target? appearance. Saw PCP due to concerns of size growth and itching with no relief from hydrocortisone cream. Recommended use of Zyrtec with hydrocortisone cream and cold compress. Recommended reporting to VAERS.
When MD was administering vaccine in the right arm ID, no visible wheal formed. Dose was repeated in the left arm immediately.
This case was reported by a consumer and described the occurrence of fever in a 11-year-old male patient who received DTaP vaccine. Concurrent medical conditions included asthma. On an unknown date, the patient receivd DTaP vaccine at an unknown dose. On an unknown date, an unknown time after receiving DTaP vaccine, the patient experienced fever, pruritus and asthma. On an unknown date, the patient experienced rash. On an unknown date, the outcome of the fever, pruritus and asthma were unknown and the outcome of the rash was unknown. It was unknown if the reporter considered the fever, pruritus, asthma and rash to be related to DTaP vaccine. Additional information: the caller reported that her grandson received a DTaP vaccine when he was 4 years old. She did not know the manufacturer of the vaccine. She reports that he developed a rash after receiving the vaccine. He also had a very high fever and was itching after receiving the vaccine. She reports that now he suffers from asthma and feels that this may be related to the vaccine. Her grandson is now 11 years old.
Initial misuse report received from a physician on 12 November 2013. The patient had administered the DTaP-IPV part of PENTACEL. (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
A non-serious spontaneous report of administration to over 49 year of age was received from a nurse practitioner/healthcare professional concerning an adult patient over 49-year-old, unknown gender. Neither relevant medical history nor concomitant medications have been reported for this patient. On 16-DEC-2009, the patient received H1N1, Intranasal. There was no adverse event associated with this vaccination error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Left arm appears red, swollen and hot to touch. Patient in discomfort. Advised to apply ice to area and may give Tylenol for discomfort. If symptoms persist patient should be seen by doctor.
01/17/03, 9AM: Hep A/B. 1AM 1/18/03 Nosebleed and he felt his BP was up 140/90. No MD this time. 02/20/03, 1PM: Hep A/B. 6AM 2/21/03 Nosebleed more serious and increased BP 140/95. He went to MD within 5 days. Stress test abnormal, 1 week BP pills. BP still increased. In one month, BP lowered, stress test normal. Pt is overweight.
Left arm vaccination site with redness and swelling burning sensation warm to touch started on 2/13/21.
He had Covid 19 2020 and recovered fully. Even though he now had natural antibodies, his Doctor convinced him that he needed the so called Covid 19 vaccine "mRNA gene therapy". On 04/29/2021, he was injected with the so called vaccine and that was the beginning of the end. On 05/10/2021, he was admitted to the Hospital with irregular heartbeat and trouble breathing. The Hospital could not get him stabilized so they transported him to another Hospital. He was there a couple of weeks or so and was now having issues with his kidneys and liver. It appeared the spike proteins had started to battle the rest of his viable organs. The hospital had to transport him to a nursing home facility because his number of days in the hospital per insurance had run out. Then on the evening of 06/13 or 14/ 2021, he became violently ill. He was taken to hospital again and was subsequently transferred back to another Hospital. The Spike proteins had now gone into overdrive attacking all his major organs. His liver, kidneys, lungs and heart were being attacked by the spike proteins created by this deadly vaccine. He was put on 24  hour dialysis and then had to be put on a ventilator. He died 06/24/2021.
Covid symptoms on 05Jul2022. Covid antigen positive; disease recurrence; Covid symptoms on 05Jul2022. Covid antigen positive; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16Dec2020 as dose 1, single (Lot number: EK5730), in left arm, on 07Jan2021 as dose 2, single (Lot number: EL1284), in left arm and on 29Oct2021 as dose 3 (booster), single (Lot number: 3013584) at the age of 36 years for covid-19 immunisation. The patient's relevant medical history included: "Celiac Disease" (unspecified if ongoing); "Psoriasis" (unspecified if ongoing); "Known allergies : PCN" (unspecified if ongoing). Concomitant medication(s) included: CABERGOLINE; COQ10 [ASCORBIC ACID;BETACAROTENE;CUPRIC OXIDE;MANGANESE SULFATE;SELENIUM;TOCOPHERYL ACETATE;UBIDECARENONE;ZINC OXIDE]; PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; VITAMIN D [VITAMIN D NOS]; ZINC. Past drug history included: C-clor, reaction(s): "Known allergies : C-clor", notes: Known allergies : C-Clor.  The following information was reported: COVID-19 (medically significant) with onset 05Jul2022, outcome "not recovered", VACCINATION FAILURE (medically significant), outcome "not recovered" and all described as "Covid symptoms on 05Jul2022. Covid antigen positive"; DISEASE RECURRENCE (medically significant) with onset 18Jul2022, outcome "not recovered". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Covid Antigen Positive; (07Jul2022) Positive; (12Jul2022) Negative, notes: No Covid symptoms and negative covid antigen test on12Jul2022; (19Jul2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19, disease recurrence.  Clinical course: Covid symptoms on 05Jul2022. Covid antigen positive and Paxlovid started on 06Jul2022. Covid per positive on 07Jul2022. No Covid symptoms and negative covid antigen teston12Jul2022.Covid symptoms restarted on 18Jul2022. Covid antigen positive on 19Jul2022. Ae treatment was Z-Pack for sinus infection.  No follow-up attempts are possible; No further information is expected.
22 y/o calls the clinic. States that he accidentally brushed his SPV site (LUE) against door in his room 4 days ago (16AUG11) and the "blister burst open". He let it air dry and then covered it with a waterproof bandage. Now reports that he has 4 red pustules with white heads located 2-3 to the right of the central Jennerian Pustule. I explained to pt that these are most likely "satellite lesions", which can develop when drainage from the central Jennerian Pustule, containing the vaccinia (vaccine) virus, touches other parts of the skin. The site care of the satellite lesions is the very same as for the primary Jennerian Pustule-keep covered at all times with a non-occlusive, regular band aid, which permits air circulation. Change band aid(s) daily. Wash hands well before and after changing daily band aid. Best to shower with band aids on, that way they will get wet and will not stick and peel off drying scabs, when trying to remove band aids. Careful with bath towel use on LUE - preferable to pat area dry with a few drops of bleach or alcohol. Keep hands away from your or anyone else's eyes, face, genitals. Don't pick at scabs or pimples. Keep band aids on till scabs fall off on their own and skin at the SPV injection/satellite lesion site(s) is completely healed. No swimming, wrestling, or exercises till scabs have fall off. If you wear contacts, remove x 2 weeks and always wash hands very well before touching eyes. Asked if pt could email me a digital photo of the area. He can come by the clinic after his training this afternoon and I will take a look at the area. Verbalized understanding of site care and compliance.
Tinnitus, which had almost completely disappeared, is now back and constant 24/7 since my first dose.
pt recv vax & w/in approx 1/2hr pt returned w/ c/o feeling SOB, dizziness, light-headedness;noted facial flushing;BP 133/88, P88, R16;cracked open an NH2 packet;pt stated did not feel better BP 108/70, P120, R24;epi given;pale, diaphoretic;
Breakthrough case admission after 2 vaccines ; Pfizer 1/27/21 Lot# EL9261;  Pfizer 2/17/21 Lot# EL926
My wife and I received a call from a friend we go to church with who let us know she had tested positive for COVID-19, that we may want to test ourselves. I took a home COVID-19 test, it came back immediately showing, I was positive. I had congestion, a low-grade fever, aches and pains, some coughing, I had a lot of congestion. I called my doctor to let him know I was positive and discussed my symptoms since I do have kidney issues. I was prescribed PAXLOVID at a half dose. Once I started taking the medication even at a half dose I started feeling better within a day. It started to feel more like a cold.
Alanine aminotransferase increased, Aspartate aminotransferase increased, Medication error. This case was reported by a nurse and described the occurrence of elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) concentrations in a 35-year old male patient who received hepatitis A vaccine inactiviated (Havrix) for prophylaxis. The patient's past medical history included hepatitis C infection, nonsteroidal anti-inflammator drug use, and intravenous drug use. This patient had no adverse experiences following previous immunizations. Baseline ALT concentration was 78; baseline AST concentration was 71. On 10 April 2003 the patient received the 1st dose of Havrix injected into the left gluteus; the prescribing information states that Havrix should not be injected in the gluteal region. On 04 June 2003, 55 days post-immunization, the patient experienced increased concentrations of ALT (315) and AST (169). On 09 July 2003, concentrations of ALT and AST were 152 and 102, respectively. Unspecified serologies for hepatitis A and hepatitis B were negative. The patient was asymptomatic. The nurse considered the events were possibly related to vaccination with Havrix.
Presents to clinic with mother received Td vaccine 9/23/02. C/O today 9/27/02 of Rt deltoid area with pain. Warm to touch. Reddened skin. Full range of motion of extremity. Asked mother to apply warm/cold compress alternating. Give acetaminophen for discomfort. Seek medical attention. Referral given as a back up. 10/1/02 called parent. Pt doing well. No c/o. Went to school 9/30/02 Monday.
This is a spontaneous report from a Pfizer-sponsored program from a contactable female consumer reporting for her son. A male patient of an unspecified age and ethnicity received the 1st dose of TRUMENBA via an unspecified route of administration on an unspecified date at 0.5ml, single. The patient medical history was and concomitant medications were not reported. The patient experienced massive fever and body aches on second day of receiving first dose. The outcome of the events was reported as recovering. The patient then received the second dose of the same vaccine and all was fine. Follow up (25Aug2016): additional information received from the same consumer includes clarification on dose of vaccine administered and body aches added as adverse event. Follow-up (21OCT2016): Follow-up attempts are completed. No further information is expected.
The Gray cap Pfizer Covid 19 vaccine for ages 12 and up was diluted with 1.3ml of 0.9% saline and then drawn up 0.3ml and administered  in error to patient under 12 years old.  Spoke to vaccine unit and they told me to contact the public health nurse, which I did and she told me to contact Pfizer to find out what they have to say about wrong vaccine given to patient. I spoke to (Privacy), RN and (Privacy), RN at Pfizer and they reviewed the Covid vaccines the gray cap 12 and older and the orange cap 5-11 years and it was determined that the dose the pt received was larger than the recommended dose and parents were notified.  Pfizer said not repeat the dose and to monitor for side effects and if they do not develop any significant side effects then they can receive their second dose 21 days later.
Information has been received from a health professional concerning her 12 month old white daughter who on 04Jan05 was vaccinated with an IM first dose in the left thigh of varicella virus vaccine live (lot649481/0764P). Concomitant vaccines administered on the same day included a first IM dose in the right thigh of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot647283/0550P) and a fourth IM dose in the left thigh of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar) (lot A74404K). There was no illness at the time of vaccination. It was reported that on 21Apr05 the pt experienced a varicella breakthrough with about 15-20 lesions. The pt was not hospitalized. It was reported that the pt was recovering. There were no lab or diagnostic tests performed. No medical attention was sought. Follow up information from a health professional indicated that on 15Apr05, at 9:00AM, the pt had a temp of about 99-100, vomited one time, had diarrhea one time, and had about 15-20 small chickenpox bumps on her face, arms and chest. It was noted that the chickenpox were very mild and did not itch or bother the child. No treatment was necessary. The pt reported as recovered on 18Apr05.
HEADACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown expiry date: unknown) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 27-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache. This report was non-serious.
Heart pain for long time; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 30 year-old male patient received BNT162B2, administered in arm left, administration date 30Nov2021 20:00 (Lot number: FJ8757) at the age of 30 years as dose 3 (booster), single for COVID-19 immunisation. No known allergies and other medical history. Prior to vaccination, the patient wasn't diagnosed with COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine, and no other medications the patient received within 2 weeks of vaccination. The patient previously received BNT162B2 (Batch/Lot No: EL3248) administered in arm left on 07Jan2021 at 04:00 PM, as dose 1; and BNT162B2 (Batch/Lot No: EL9265) administered in arm right on 28Jan2021 at 06:00 PM as dose 2; both at 29 years old for COVID-19 immunization. The following information was reported: ANGINA PECTORIS (medically significant) with onset 02Dec2021 12:00, outcome "not recovered", described as "Heart pain for long time". Therapeutic measures were not taken as a result of angina pectoris. Since the vaccination, it's unknown if the patient has been tested for COVID-19.  Follow-Up (07Dec2021): Follow-up attempts are completed. No further information is expected.
States left arm swollen about the size of her palm. Warm to touch. It was tender yesterday, but not tender today. A little itching.
After 10 minutes receiving the 1st dose of Pfizer Covid-19 vaccine, patient experienced sweating, pale looking, eyes rolling back. He was still aware, and stated that he wants to lye down. We took his BP, all the numbers are within normal range.  He rested for 15 more minutes, and said that he wants to go home and rest.  We called to followed up later and talked to Mom. She said he is ok after eating  and resting.
Patient refers dizziness, nausea, pain after administration of the HPV vaccine. She is kept under observation until the patient refers not having nausea, indicating that she has only a little dizziness, indicating that she feels better. 11:26 am patient leaves the vaccination area alert, oriented and walking in the company of mother.
Narrative:  Fully vaccinated, admitted for increased confusion in setting of thiamine deficiency and COVID positive
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (My arm is sore) and HEADACHE (I had a headache) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088D211A) for COVID-19 vaccination. No Medical History information was reported. On 09-Aug-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Aug-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (I had a headache). On 10-Aug-2021, the patient experienced VACCINATION SITE PAIN (My arm is sore). The patient was treated with IBUPROFEN for Headache, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (My arm is sore) and HEADACHE (I had a headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication information was provided.
Information has been received from a medical assistant on 02-JUL-2015 concerning a patient of an unknown age and gender. On 03-APR-2015, the patient was vaccinated with a dose of RECOMBIVAX HB 0.5 ml, lot # K010535, (expiration date, route and site of administration were not reported) that underwent 72 hours temperature excursion outside of the recommended range. No adverse effects had been observed or reported. This is one of several reports from the same reporter. Additional information has been requested.
Very high fever (103 on NSAID) and severe abdominal cramping Went to urgent care and received toradol injection
Saturday 04/24/2021: Around noon time, a sudden sharp pain at a spot in the left hip joint area. It affected normal mobility: could walk as normal but when across a purse on the floor, the pain was enough to make it hard to do as usual. As the day went, the pain extended to the back of the upper leg area. It was a mild but dull pain; I had never had the same kind of pain. From 04/25/2021 to Friday 05/14/2021, The pain was persisted and remained in the back of the upper left leg area. Saturday 05/15: The same pain got much worse.
Pt recv vax on 9/17/98; on same day pt exp hypoglycemia sxs of cold, sweats & near syncope